Menu

News & Insights

  • Clear

FTC Files Amicus Brief in Pharmaceutical Antitrust Case

The FTC has filed an amicus brief in an antitrust case alleging that drug manufacturer Johnson & Johnson illegally maintained a monopoly through anticompetitive conduct. The brief argues that the Supreme Court precedent establishes that antitrust law is focused on the impact of anticompetitive conduct, not on the intent to harm competition. CareFirst of Maryland…

Read More

AG James Multistate Coalition Secures $36.5 Million from CVS in Medicaid Fraud Settlement

New York AG Letitia James has joined a bipartisan coalition of 36 AGs, and the United States Department of Justice (DOJ) has secured a $36.5 million settlement from CVS Pharmacy Inc (CVS) for fraudulently overbilling Medicaid for insulin prescriptions. The lawsuit claims that CVS knowingly dispensed more insulin to customers than they needed while maintaining…

Read More

Arizona AG Says Insurers Used Algorithm to Fix Out-of-Network Rates

Arizona AG Kris Mayes sued MultiPlan and several major health insurers, alleging violations of the Arizona Uniform State Antitrust Act and Arizona Consumer Fraud Act based on an alleged price-fixing scheme to suppress payments for out-of-network care. According to the complaint, the insurers allegedly used MultiPlan’s shared pricing algorithm and pooled confidential claims and payment…

Read More

Massachusetts AG Accuses UnitedHealthcare of Inflating Medicaid Reimbursements

Massachusetts AG Andrea Joy Campbell sued UnitedHealthcare Insurance Company, d/b/a UnitedHealthcare Community Plans of Massachusetts, asserting Massachusetts False Claims Act, unjust enrichment, and breach of contract claims over allegations that the insurer inflated health-status assessments for seniors enrolled in its MassHealth Senior Care Options plan. According to the complaint, UnitedHealthcare improperly moved members into higher-paying…

Read More

Illinois AG Pens Latest EpiPen Deal With Mylan

Illinois AG Kwame Raoul reached an $8.25 million settlement with Mylan Inc. resolving allegations that the company used anticompetitive tactics to monopolize the epinephrine auto-injector market and overcharge Illinois Medicaid and employee health benefits programs for EpiPens. According to the AG’s office, Mylan allegedly raised prices, delayed generic competition, forced consumers to buy two-packs instead…

Read More